Morphological alterations and DNase deficiency in phenobarbital promotion of N-nitrosomorpholine initiated rat hepatocarcinogenesis.
Tumorigenic effect in rat liver was increased when phenobarbital was given chronically after N-nitrosomorpholine. In these rats the liver parenchyma surrounding pre- and neo-plastic lesions demonstrated distinct, mainly centrilobular zones of hypertrophic hepatocytes with abundant eosinophilic, filamentous cytoplasm, increase in nucleic acids and decrease in DNase activity. These alterations might be considered as signs of tumor-promoting activity of phenobarbital.
D000818:Animals; D002273:Carcinogens / Q000633:toxicity*; D003851:Deoxyribonucleases / Q000172:deficiency*; D004357:Drug Synergism; D008099:Liver / Q000187:drug effects* / Q000473:pathology; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D009374:Neoplasms, Experimental / Q000139:chemically induced; D009602:Nitrosamines / Q000633:toxicity*; D010634:Phenobarbital / Q000633:toxicity*; D011230:Precancerous Conditions / Q000473:pathology; D051381:Rats; D011919:Rats, Inbred Strains
D002273:Carcinogens; D009602:Nitrosamines; C002741:N-nitrosomorpholine; D003851:Deoxyribonucleases; D010634:Phenobarbital